Table 1. Dyslipidemia Diagnostic Criteria.

LDL‐C	≥ 140 mg/dL	Hyper‐LDL Cholesterolemia
	120 ‐ 139 mg/dL	Borderline hyper‐LDLcholesterolemia＊＊
HDL‐C	＜40 mg/dL	Hypo‐HDL Cholesterolemia
TG	≥ 150 mg/dL (fasting＊)	Hypertriglyceridemia
	≥ 175 mg/dL (non‐fasting, any time＊)
Non‐HDL Cholesterol	≥ 170 mg/dL	Hyper‐non‐HDL cholesterolemia
	150 ‐ 169 mg/dL	Borderline hyper‐non‐HDL cholesterolemia＊＊

^＊Fasting for more than 10 hours is considered ‘fasting’. However, the consumption of noncaloric fluids such as water and tea is acceptable. If the patient is not confirmed to fast, it is defined as ‘non‐fasting’ or ‘anytime’.

^＊＊If screening shows borderline hyper‐LDL cholesterolemia or borderline hyper‐non‐HDL cholesterolemia, investigate whether there are any high‐risk conditions and consider the need for treatment.

‐ LDL‐C is calculated using the Friedewald formula (TC－HDL‐C－TG/5) (only for fasting blood samples), or through a direct method.

‐ If TG is ＞400 mg/dL or non‐fasting blood is collected, use non‐HDL‐C (=TC－HDL‐C) or LDL‐C direct method. However, when non‐HDL‐ C is used in the screening, the risk should be evaluated with the possibility that the difference from LDL‐C may be less than +30 mg/dL in the absence of hypertriglyceridemia.

‐ The cut‐off value for TG varies depending on whether the blood is collected fasting or non‐fasting.

‐ HDL‐C alone is not a target for drug intervention